Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023

BUY
$2.58 - $3.68 $13,029 - $18,584
5,050 Added 21.96%
28,050 $77,000
Q2 2022

Jul 13, 2022

SELL
$2.95 - $5.85 $2 - $5
-1 Reduced -0.0%
23,000 $67,000
Q1 2022

May 12, 2022

BUY
$3.3 - $5.69 $75,903 - $130,875
23,001 New
23,001 $120,000

Others Institutions Holding BRTX

About BioRestorative Therapies, Inc.


  • Ticker BRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 3,650,030
  • Market Cap $5.4M
  • Description
  • BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtx...
More about BRTX
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.